Back to Search Start Over

1618P Durable efficacy of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion positive (NRG1+) pancreatic ductal adenocarcinoma (PDAC).

Details

Language :
English
ISSN :
09237534
Volume :
34
Database :
Academic Search Index
Journal :
Annals of Oncology
Publication Type :
Academic Journal
Accession number :
173099262
Full Text :
https://doi.org/10.1016/j.annonc.2023.09.2567